Endomedix partnered with a catalyst with extensive experience in the hemostatic sealant market place at the tTAp. See Endomedics in action at the tTAp

– Endomedix selected as NIH featured at Bio 2015

– Endomedix receives a $1.5 M NIH Grant


Providing a less expensive sealant and hemostat for use during surgical procedures. Seeking to be used particularly for neuro applications.

  • Technology Presenter: Richard Russo
  • Commercial Catalysts: Meg Helms, Morgan Wallace